mannitol has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egoz-Matia, N; Frenkel-Pinter, M; Gazit, E; Levy-Sakin, M; Masliah, E; Patrick, C; Rockenstein, E; Schiller, A; Segal, D; Shaltiel-Karyo, R | 1 |
| Meddings, J; Ranawaya, R; Salat-Foix, D; Suchowersky, O; Tran, K | 1 |
| Barrett, JA; Billington, D; Davies, KN; King, D | 1 |
| Kroll, RA; Neuwelt, EA | 1 |
1 review(s) available for mannitol and Parkinson Disease
| Article | Year |
|---|---|
Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Bradykinin; Brain Neoplasms; Clinical Trials, Phase I as Topic; Cognition Disorders; Cranial Irradiation; Dogs; Forecasting; Genetic Therapy; Hearing Loss; Humans; Hypertonic Solutions; Immunotoxins; Life Tables; Lysosomal Storage Diseases; Mannitol; Osmotic Pressure; Parkinson Disease; Pharmacokinetics; Quality of Life; Rats; Rats, Nude; Survival Analysis | 1998 |
3 other study(ies) available for mannitol and Parkinson Disease
| Article | Year |
|---|---|
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD).
Topics: alpha-Synuclein; Amyloid; Animals; Antiparkinson Agents; Benzothiazoles; Blood-Brain Barrier; Drosophila; Female; Fluorescent Dyes; Hippocampus; HSP70 Heat-Shock Proteins; Humans; Locomotion; Male; Mannitol; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Microscopy, Electron, Transmission; Neocortex; Parkinson Disease; Protein Multimerization; Protein Structure, Secondary; Thiazoles | 2013 |
Increased intestinal permeability and Parkinson disease patients: chicken or egg?
Topics: Aged; Aged, 80 and over; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Lactulose; Male; Mannitol; Middle Aged; Parkinson Disease; Permeability; Sucrose | 2012 |
Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Breath Tests; Case-Control Studies; Female; Gastrointestinal Transit; Humans; Intestinal Absorption; Intestine, Small; Lactulose; Male; Mannitol; Parkinson Disease; Permeability | 1996 |